QNTM: Quantum BioPharma Limited Company Value to Net Income

Corporate emblem and logo of Quantum BioPharma Ltd. (QNTM)

Quantum BioPharma Ltd (QNTM) focuses on health restoration, aiming for dominance in niche medical segments through innovative R&D developments. The business relies on a multi-purpose environment of therapeutic solutions and dietary supplements, integrating its manufacturing plants with research centers. The indicator stands at -0.60. This price chart on GURU.Markets, serving as confirmation of the market valuation, complements data on standard laboratory environmental controls.

QNTM Quantum BioPharma Corp: Price to Earnings Ratio in the range 08/16/2024 - 11/12/2026

Comprehensive metric breakdowns and analytics for Quantum BioPharma Limited (QNTM)

- price and consensus price forecast:
Comprehensive company analysis:quantumbiopharma.com - QNTM
Flagship merchandise of Quantum BioPharma

To build a high-quality portfolio, I utilize this multiple as a measure of a business's market value relative to its ability to generate real cash flow. By analyzing the adjusted P/E of Quantum BioPharma Ltd (QNTM), an investor assesses the return on investment, which is critical for Quantum BioPharma Ltd (QNTM) during the implementation of robotic screening and data automation, where the high cost of innovation may temporarily distort the asset's fundamental valuation.

Analysis of competing companies

P/E Multiple haleon.com|Price to Earnings Ratio KVUE (Kenvue)|VRNA (Verona Pharma PLC) - Company Value to Net Income|Price to Earnings Ratio Jyong Biotech Corp MENS|Ligand Corp (LGND) - Market Cap to Earnings|AMRX: Price to Earnings Ratio|perrigo.com - Market Price to Net Income Ratio|ALVO: P/E Multiple|Liquidia Corp - Company Value to Net Income|GLPG (Galapagos Genomics) - P/E Multiple|Market Cap to Earnings ANI Pharmaceuticals Corp ANIP|Price to Earnings Ratio MannKind Corporation (MNKD)|AMPH (amphastar.com) - Company Value to Net Income|Price to Earnings Ratio Pacira BioSciences, Inc. PCRX|Market Cap to Net Income Ratio ARS Pharmaceuticals Inc|TBPH: Price to Earnings Ratio|AQST - P/E Multiple|SCPH: P/E Multiple|Tectonic Therapeutic (TECX) - P/E Multiple|Price to Earnings Ratio Tonix Pharmaceuticals Holding Corp.|Price to Earnings Multiple SXTC (SXT China)|Price to Earnings Ratio EPRX (Eupraxia Pharmaceuticals)|Market Price to Net Income Ratio BHST|eXoZymes Inc - Price to Earnings Ratio|P/E Multiple Oramed ORMP|ENTX - Price to Earnings Ratio|MindWalk Holdings, Inc. (HYFT) - Price to Earnings Ratio|ABVC (ABVC BioPharma Inc) - Price to Earnings Ratio|Cumberland Corp - Company Value to Net Income|FGEN (FibroGen, Inc.) - P/E Multiple|Price to Earnings Ratio TELO|P/E Multiple RANI|Business Payback Period synergychc.com|Price to Earnings Ratio Rallybio RLYB|Lexaria Bioscience Corp (LEXX) - Market Cap to Earnings|PULM - Price to Earnings Ratio|Market Cap to Net Income PTHL|APM: P/E Multiple|Lyra Therapeutics Inc. - Company Value to Net Income|IBO (Impact BioMedical) - P/E Multiple|P/E Multiple TNF Pharma|Price to Earnings Ratio cbdMD, Inc. (YCBD)|PRFX (painreform.com) - Company Value to Net Income|Price to Earnings Ratio Altamira Therapeutics Ltd. CYTO|LIPO - Price to Earnings Ratio|Optinose - P/E Multiple|PIRS - P/E Multiple|PROC (Procaps Group S.A.) - Price to Earnings Ratio|petrospharma.com - Company Value to Net Income|Price to Earnings Ratio Qilian International Holding|Price to Earnings Ratio SLRN|Price to Earnings Ratio TFFP (TFF Pharma)